Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1106 - Genomic characterization of chronic lymphocytic leukemia patients with TP53 alterations from a spanish real-world cohort treated with targeted agents

    Primary Author / Presenter(s)

  • JK

    Joanna Kamaso, PhD Student

    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM)
    Barcelona, Spain

    • Co-Author(s)

  • Silvia Ramos-Campoy

    PhD Student
    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM)
    Barcelona, Catalonia, Spain

  • CM

    Carme Melero, Tech

    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain/Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain, Spain

  • MS

    Marta Salido, PhD

    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM)
    Barcelona, Spain

  • ML

    Marta Lorenzo, tech

    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain
    Barcelona, Catalonia, Spain

  • MR

    María Rodríguez-Rivera

    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)
    Barcelona, Spain

  • EG

    Eva Gimeno

    MD PhD
    Department of Hematology, Hospital del Mar
    Barcelona, Catalonia, Spain

  • MA

    Miguel Alcoceba, PhD

    Head of Department
    Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
    Salamanca, Castilla y Leon, Spain

  • Miguel Bastos-Boente, PhD candidate

    PhD Candidate
    Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
    Salamanca, Castilla y Leon, Spain

  • R

    Ángel Ramírez Payer, MD

    Hematology Department
    Hospital Universtiario Central de Asturias
    Oviedo, Asturias, Spain

  • AR

    Alicia Rodríguez, MD

    Hematologist
    Hospital Universitario Virgen Macarena
    Sevilla, Andalucia, Spain

  • S

    Ángel Serna, MD

    Department of Hematology, Vall d´Hebron University Hospital
    Barcelona, Catalonia, Spain

  • PA

    Pau Abrisqueta, MD, PhD

    Hematologist
    Department of Hematology, Vall d´Hebron University Hospital
    Barcelona, Catalonia, Spain

  • MC

    Marta Crespo, PhD

    Vall d'Hebron Institute of Oncology (VHIO)
    Barcelona, Catalonia, Spain

  • AC

    Alba Cabirta, MD

    Department of Hematology, Vall d´Hebron University Hospital, Barcelona, Spain
    Barcelona, Catalonia, Spain

  • RS

    Raquel Santiago, MD

    Hospital Sant Joan de Déu de Manresa, Manresa
    Manresa, Catalonia, Spain

  • LG

    Lola García, MD

    Hospital General Universitario Morales Meseguer
    Murcia, Spain

  • AO

    Ana C. Oliveira, MD, PhD

    Clinical Hematology Senior Consultant
    Institut Català d'Oncologia - Hospital Duran i Reynals, IDIBELL, Hospitalet, Catalonia, Spain

  • AS

    Alicia Serrano Alcala

    INCLIVA Biomedical Research Institute, Valencia 46010, Spain.
    Valencia, Comunidad Valenciana, Spain

  • BF

    Blanca Ferrer-Lores, MD

    Department of Hematology, Hospital Clínico Universitario-INCLIVA
    Valencia, Comunidad Valenciana, Spain

  • MP

    Miguel Perera, PhD

    Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria
    Las Palmas de Gran Canarias, Canarias, Spain

  • AS

    Alexia Suárez Cabrera, MD

    Hospital Universitario de Gran Canaria Dr. Negrín
    Las Palmas, Canarias, Spain

  • MO

    Macarena Ortiz, MD

    Hospital Regional Universitario de Málaga, Málaga
    Malaga, Andalucia, Spain

  • RC

    Rosa Collado, PhD

    -
    Consorcio Hospital General Universitario de Valencia
    Valencia, Comunidad Valenciana, Spain

  • RG

    Rocío García-Serra, MSc

    Laboratory for the Cytogenetic and Molecular Diagnosis of Hematological Malignancies, Centre for Human Genetics, University Hospitals Leuven, Leuven, Belgium/Department of Hematology, Consorcio Hospital General Universitario, Valencia, Spain/Research Foundation from Hospital General Universitario, Valencia, Spain
    Consorcio Hospital General Universitario de Valencia
    Valencia, Spain

  • TV

    Teresa Villalobos, MD

    Hospital Universitari MútuaTerrassa, Terrassa
    Terrassa, Catalonia, Spain

  • MJ

    Marta Julià, MD

    Hospital Universitari Germans Trias i Pujol, Badalona
    Badalona, Catalonia, Spain

  • SR

    Sergio Ramos, MD

    Hospital Universitario Fundación Jiménez Díaz, Madrid
    Madrid, Madrid, Spain

  • GA

    Gemma Azaceta, MD

    Hospital Clínico Universitario Lozano Blesa, Zaragoza
    Zaragoza, Aragon, Spain

  • Jd

    Janilson do Nascimiento, MD

    Hospital Universitari Joan XXIII, Tarragona
    Tarragona, Catalonia, Spain

  • RA

    Rafael Andreu, MD

    Hematologist
    Hospital Universitari i Politècnic La Fe, València
    Valencia, Spain

  • O

    íñigo Olazabal, MD

    Hospital Universitario Donostia, Donostia-San Sebastián
    Donostia-San Sebastián, Pais Vasco, Spain

  • Javier de la Serna, MD

    Servicio de Hematologia
    Hospital Universitario 12 de Octubre
    Madrid, Spain

  • ER

    Eduardo Ríos, MD

    Hospital Nuestra Señora de Valme
    Sevilla, Andalucia, Spain

  • JA

    José María Arguiñano, MD

    Hospital Universitario de Navarra, Pamplona
    Pamplona, Navarra, Spain

  • MR

    Miguel Ángel Rodríguez, MD

    Hospital Universitario Virgen de las Nieves, Granada
    Granada, Andalucia, Spain

  • AF

    Ainara Ferrero, MD

    Hospital Universitari Arnau de Vilanova, Lleida
    Lleida, Catalonia, Spain

  • LY

    Lucrecia Yáñez, MD, PhD

    Hematologist
    Hospital Universitario Marqués de Valdecilla
    Santander, Cantabria, Spain

  • Ed

    Emil de León, MD

    Hospital Médico-Quirúrgico de Jaén, Jaén
    Jaén, Andalucia, Spain

  • IG

    Isabel González-Gascón y Marín, MD

    Hospital Universitario Infanta Leonor
    Madrid, Spain

  • JL

    Javier Loscertales, MD

    Hematology staff
    Hospital Universitario de La Princesa
    Madrid, Spain

  • XG

    Xabier Gutiérrez, MD

    Hospital Universitario Araba – Txagorritxu, Vitoria
    Vitoria, Pais Vasco, Spain

  • AM

    Ana Muntañola, MD

    Hospital de la Santa Creu i Sant Pau, Barcelona
    Barcelona, Catalonia, Spain

  • Miguel Arguello-Tomas, MD, MSc

    CLINICAL HEMATOLOGIST
    Hospital de la Santa Creu i Sant Pau
    Barcelona, Catalonia, Spain

  • M

    Ángeles Medina, MD

    Hospital Costa del Sol
    Marbella, Andalucia, Spain

  • MC

    MªVictoria Calle, MD

    Hospital Universitario Torrecárdenas, Almería
    Almería, Andalucia, Spain

  • CF

    Christelle Ferrà

    Hematology Consultant
    Department of Hematology, Hospital del Mar, Barcelona, Spain
    Barcelona, Catalonia, Spain

  • FB

    Francesc Bosch, MD, PhD

    Head, Dept of Hematology; Director, Experimental Hematology (VHIO); Professor
    Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron
    Barcelona, Catalonia, Spain

  • AP

    Anna Puiggros, PhD

    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM)
    Barcelona, Catalonia, Spain

  • BE

    Blanca Espinet, PhD

    Head Molecular Cytogenetics Laboratory
    Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM)
    Barcelona, Catalonia, Spain